{
    "organizations": [],
    "uuid": "8d71bea2aa6dc60b47a09bf7fcee5c7b4d87e040",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-arrowhead-pharmaceuticals-receives/brief-arrowhead-pharmaceuticals-receives-orphan-drug-designation-for-aro-aat-idUSFWN1Q51EV",
    "ord_in_thread": 0,
    "title": "BRIEF-Arrowhead Pharmaceuticals Receives Orphan Drug Designation For ARO-AAT",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 15 (Reuters) - Arrowhead Pharmaceuticals Inc:\n* ARROWHEAD PHARMACEUTICALS RECEIVES ORPHAN DRUG DESIGNATION FOR ARO-AAT\n* ARROWHEAD PHARMA- U.S. FDA GRANTED ORPHAN DRUG DESIGNATION TO ARO-AAT FOR TREATMENT OF A RARE GENETIC LIVER DISEASE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-16T04:54:00.000+02:00",
    "crawled": "2018-02-16T17:05:05.054+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "arrowhead",
        "pharmaceutical",
        "inc",
        "arrowhead",
        "pharmaceutical",
        "receives",
        "orphan",
        "drug",
        "designation",
        "arrowhead",
        "fda",
        "granted",
        "orphan",
        "drug",
        "designation",
        "treatment",
        "rare",
        "genetic",
        "liver",
        "disease",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}